However, no significant association was found between IGF2BP2 expression and other clinical parameters, including age (<55 vs. ≥55 years), gender, lymph node metastasis (negative vs. positive), tumor stage (I–IV), or histologic grade (low, intermediate, high). The gene discussed is IGF2BP2; the disease is neoplasm.